| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | developmental growth | SOX2 ATRN NLGN4Y IST1 ZEB2 ZFPM2 PTK7 GJA1 ARHGAP4 KMT2C LATS1 SALL1 NLGN4X TIAM1 VPS13A PRKG1 TNKS2 PRLR | 1.13e-06 | 911 | 108 | 18 | GO:0048589 |
| GeneOntologyBiologicalProcess | regulation of lipid kinase activity | 2.23e-05 | 11 | 108 | 3 | GO:0043550 | |
| GeneOntologyBiologicalProcess | regulation of myofibroblast cell apoptotic process | 2.72e-05 | 2 | 108 | 2 | GO:1904520 | |
| GeneOntologyBiologicalProcess | myofibroblast cell apoptotic process | 2.72e-05 | 2 | 108 | 2 | GO:1904516 | |
| GeneOntologyBiologicalProcess | aggressive behavior | 3.84e-05 | 13 | 108 | 3 | GO:0002118 | |
| GeneOntologyBiologicalProcess | growth | SOX2 ATRN NLGN4Y IST1 ZEB2 ZFPM2 PTK7 GJA1 ARHGAP4 KMT2C LATS1 SALL1 NLGN4X TIAM1 VPS13A PRKG1 TNKS2 PRLR | 7.06e-05 | 1235 | 108 | 18 | GO:0040007 |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 7.44e-05 | 16 | 108 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | TBX15 SOX2 ABI1 ZEB2 ZFPM2 PTK7 GJA1 C2CD3 LATS1 PBRM1 SALL1 HOXD3 SEC24B UNK PRRC2B | 7.50e-05 | 906 | 108 | 15 | GO:0043009 |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 8.12e-05 | 3 | 108 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | TBX15 SOX2 ABI1 ZEB2 ZFPM2 PTK7 GJA1 C2CD3 LATS1 PBRM1 SALL1 HOXD3 SEC24B UNK PRRC2B | 9.92e-05 | 929 | 108 | 15 | GO:0009792 |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 1.38e-04 | 368 | 108 | 9 | GO:0030111 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 1.49e-04 | 372 | 108 | 9 | GO:0060485 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 1.62e-04 | 4 | 108 | 2 | GO:0008049 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 1.61e-04 | 4 | 109 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | eukaryotic translation elongation factor 1 complex | 1.61e-04 | 4 | 109 | 2 | GO:0005853 | |
| Domain | Transl_elong_EF1A_euk/arc | 3.07e-05 | 2 | 104 | 2 | IPR004539 | |
| Domain | Dppa3 | 3.07e-05 | 2 | 104 | 2 | IPR029096 | |
| Domain | NLGN4 | 3.07e-05 | 2 | 104 | 2 | IPR030025 | |
| Domain | PGC7_Stella | 3.07e-05 | 2 | 104 | 2 | PF15549 | |
| Domain | HMG | 2.32e-04 | 54 | 104 | 4 | SM00398 | |
| Domain | Nlgn | 3.04e-04 | 5 | 104 | 2 | IPR000460 | |
| Pubmed | RANBP2 WBP11 ABI1 APC2 HECTD4 EWSR1 PABPC1 ZEB2 EEF1A1 EEF1A2 PBRM1 NAV1 BSN WNK2 PRRC2B PHLDB2 MTSS2 | 9.94e-09 | 963 | 110 | 17 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG PHACTR2 ABI1 PABPC1 TRAK1 EEF1A1 EEF1A2 C2CD3 LATS1 TIAM1 SEC24B NAV1 R3HDM1 SMAP2 PHLDB2 MTSS2 | 1.38e-08 | 861 | 110 | 16 | 36931259 |
| Pubmed | ATRN ZSWIM8 WBP11 RBL2 APC2 HECTD4 IST1 MRPS35 NCAM2 EWSR1 POGZ ZEB2 HNRNPF EEF1A1 EEF1A2 TIAM1 TNKS2 R3HDM1 | 1.17e-07 | 1285 | 110 | 18 | 35914814 | |
| Pubmed | 4.44e-07 | 48 | 110 | 5 | 26590968 | ||
| Pubmed | ZSWIM8 WBP11 ATXN7L2 IST1 EWSR1 HNRNPF ZFPM2 IGHM UNK R3HDM1 WNK2 PRRC2B | 5.42e-07 | 608 | 110 | 12 | 16713569 | |
| Pubmed | SOX2 WBP11 ATXN7L2 MRPS35 EWSR1 POGZ PABPC1 ZEB2 ZFPM2 KMT2C FAT1 PBRM1 SALL1 SEC24B UNK R3HDM1 SMAP2 PRRC2B | 5.52e-07 | 1429 | 110 | 18 | 35140242 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.09e-06 | 167 | 110 | 7 | 20362541 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SYNRG SETD1B ANXA11 HECTD4 AKNA TRAK1 KMT2C HEYL FAT1 C2CD3 OSBPL5 NAV1 WNK2 RIC1 PRRC2B | 2.17e-06 | 1105 | 110 | 15 | 35748872 |
| Pubmed | The Tlx gene regulates the timing of neurogenesis in the cortex. | 4.99e-06 | 11 | 110 | 3 | 15385616 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | ZSWIM8 RBL2 MRPS35 PABPC1 HNRNPF EEF1A1 EEF1A2 FAT1 PBRM1 ANKRD40 PHLDB2 | 6.09e-06 | 639 | 110 | 11 | 23443559 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TBX15 SOX2 AKNA POU2F2 ZEB2 ZFPM2 HEYL SALL1 HOXD3 WDHD1 EGR3 NR2E1 ZNF541 | 6.18e-06 | 908 | 110 | 13 | 19274049 |
| Pubmed | 7.34e-06 | 529 | 110 | 10 | 14621295 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 7.38e-06 | 146 | 110 | 6 | 23892456 | |
| Pubmed | ZSWIM8 RANBP2 CHERP ANXA11 EWSR1 POGZ PABPC1 HNRNPF PBRM1 LTA4H PRRC2B | 7.46e-06 | 653 | 110 | 11 | 22586326 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 9.59e-06 | 430 | 110 | 9 | 35044719 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 25470546 | ||
| Pubmed | eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency. | 9.91e-06 | 2 | 110 | 2 | 30782564 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 31876369 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 23183221 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 11231076 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 24855039 | ||
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 9.91e-06 | 2 | 110 | 2 | 37001827 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 35741005 | ||
| Pubmed | The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders. | 9.91e-06 | 2 | 110 | 2 | 30370994 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26212729 | ||
| Pubmed | Molecular cloning and functional analysis of a novel Cx43 partner protein CIP150. | 9.91e-06 | 2 | 110 | 2 | 16112082 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 17825975 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 18434543 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 22095224 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 38220433 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 19636410 | ||
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 9.91e-06 | 2 | 110 | 2 | 37080762 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 29106499 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 9.91e-06 | 2 | 110 | 2 | 24104404 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 33098486 | ||
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 9.91e-06 | 2 | 110 | 2 | 32243781 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 22989184 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 33628342 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 7945283 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 32347192 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.00e-05 | 154 | 110 | 6 | 16055720 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RANBP2 WBP11 CHERP SALL3 ANXA11 EWSR1 POGZ PABPC1 HNRNPF EEF1A1 EEF1A1P5 EEF1A2 SALL1 | 1.05e-05 | 954 | 110 | 13 | 36373674 |
| Pubmed | 1.20e-05 | 159 | 110 | 6 | 22751105 | ||
| Pubmed | RANBP2 WBP11 PHACTR2 MRPS35 PABPC1 ZEB2 HNRNPF PTK7 EEF1A1 EEF1A2 C2CD3 LATS1 VPS13A BSN ZNF541 PRRC2B | 1.24e-05 | 1442 | 110 | 16 | 35575683 | |
| Pubmed | 1.36e-05 | 15 | 110 | 3 | 8812466 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.67e-05 | 351 | 110 | 8 | 38297188 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 1.69e-05 | 462 | 110 | 9 | 31138677 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 1.80e-05 | 256 | 110 | 7 | 24189400 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATRN MAN2B2 NLGN4Y PPFIBP2 HECTD4 NCAM2 ADGRV1 HNRNPF PTK7 ITFG1 EEF1A2 KMT2C OSBPL5 NAV1 WNK2 RIC1 | 1.84e-05 | 1489 | 110 | 16 | 28611215 |
| Pubmed | Murine inner cell mass-derived lineages depend on Sall4 function. | 2.43e-05 | 18 | 110 | 3 | 17060609 | |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 2.60e-05 | 109 | 110 | 5 | 33554859 | |
| Pubmed | 2.78e-05 | 274 | 110 | 7 | 34244482 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 33692755 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 19559761 | ||
| Pubmed | Endogenous retroviruses are associated with hippocampus-based memory impairment. | 2.97e-05 | 3 | 110 | 2 | 31792184 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 22194602 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 37429391 | ||
| Pubmed | SPLUNC1 and MLL3 regulate cancer stem cells in nasopharyngeal carcinoma. | 2.97e-05 | 3 | 110 | 2 | 31646828 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 32011705 | ||
| Pubmed | Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins. | 2.97e-05 | 3 | 110 | 2 | 25576924 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 18628683 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 18448518 | ||
| Pubmed | Expression of three spalt (sal) gene homologues in zebrafish embryos. | 2.97e-05 | 3 | 110 | 2 | 12590351 | |
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 2.97e-05 | 3 | 110 | 2 | 21282647 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 37956771 | ||
| Pubmed | 3.92e-05 | 396 | 110 | 8 | 26687479 | ||
| Pubmed | 3.93e-05 | 21 | 110 | 3 | 32492250 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 4.07e-05 | 398 | 110 | 8 | 35016035 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SYNRG RANBP2 CHERP IST1 PABPC1 HNRNPF EEF1A2 MAVS SEC24B AK2 LTA4H PRRC2B | 4.14e-05 | 934 | 110 | 12 | 33916271 |
| Pubmed | 4.54e-05 | 22 | 110 | 3 | 31493975 | ||
| Pubmed | 4.76e-05 | 407 | 110 | 8 | 12693553 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 5.09e-05 | 411 | 110 | 8 | 35182466 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | WBP11 CHERP ANXA11 MRPS35 EWSR1 PABPC1 HNRNPF EEF1A1 UNK R3HDM1 PRRC2B | 5.20e-05 | 807 | 110 | 11 | 22681889 |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 11294870 | ||
| Pubmed | Regulation and function of Spalt proteins during animal development. | 5.92e-05 | 4 | 110 | 2 | 19247946 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 20382729 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 16598713 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 23386720 | ||
| Pubmed | OCAM regulates embryonic spinal cord stem cell proliferation by modulating ErbB2 receptor. | 5.92e-05 | 4 | 110 | 2 | 25875008 | |
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 5.92e-05 | 4 | 110 | 2 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 5.92e-05 | 4 | 110 | 2 | 22671294 | |
| Pubmed | Identification of regulators of chaperone-mediated autophagy. | 5.92e-05 | 4 | 110 | 2 | 20797626 | |
| Pubmed | Rapid generation of a mouse model for Middle East respiratory syndrome. | 5.92e-05 | 4 | 110 | 2 | 24599590 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 20579107 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 16545361 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 16077734 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 17292328 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 22308431 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 15013623 | ||
| Pubmed | Par3 is essential for the establishment of planar cell polarity of inner ear hair cells. | 5.94e-05 | 24 | 110 | 3 | 30814219 | |
| Pubmed | WBP11 IST1 EWSR1 GJA1 LATS1 WDHD1 MAVS SEC24B UNK R3HDM1 SMAP2 PRRC2B | 8.48e-05 | 1007 | 110 | 12 | 34597346 | |
| Pubmed | 8.75e-05 | 709 | 110 | 10 | 22988430 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 9.69e-05 | 231 | 110 | 6 | 16452087 | |
| Pubmed | Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis. | 9.85e-05 | 5 | 110 | 2 | 35168003 | |
| Pubmed | Sall1 regulates embryonic stem cell differentiation in association with nanog. | 9.85e-05 | 5 | 110 | 2 | 21062744 | |
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 9.85e-05 | 5 | 110 | 2 | 18923512 | |
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 37865312 | ||
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 18649364 | ||
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 23720416 | ||
| Interaction | YWHAG interactions | SOX2 SYNRG PHACTR2 ABI1 PPFIBP2 HECTD4 NCAM2 EWSR1 PABPC1 DPPA3 TRAK1 EEF1A1 C2CD3 LATS1 TIAM1 SEC24B ERRFI1 NAV1 UNK R3HDM1 SMAP2 PRLR PHLDB2 MTSS2 | 1.92e-08 | 1248 | 105 | 24 | int:YWHAG |
| Interaction | YWHAH interactions | SYNRG PHACTR2 ABI1 PPFIBP2 HECTD4 NCAM2 TRAK1 EEF1A1 EEF1A2 C2CD3 LATS1 TIAM1 SEC24B ERRFI1 OSBPL5 NAV1 R3HDM1 SMAP2 WNK2 PHLDB2 MTSS2 | 2.03e-07 | 1102 | 105 | 21 | int:YWHAH |
| Interaction | R3HDM1 interactions | 2.77e-07 | 84 | 105 | 7 | int:R3HDM1 | |
| Interaction | ESRRB interactions | SOX2 EWSR1 HNRNPF EEF1A1 EEF1A1P5 EEF1A2 KMT2C PBRM1 SALL1 ERRFI1 | 1.13e-06 | 262 | 105 | 10 | int:ESRRB |
| Interaction | YWHAZ interactions | SOX2 SYNRG ABI1 PPFIBP2 HECTD4 NCAM2 EWSR1 TRAK1 EEF1A1 GJA1 LATS1 TIAM1 ERRFI1 NAV1 UNK R3HDM1 ANKRD40 PRLR WNK2 PHLDB2 MTSS2 | 3.70e-06 | 1319 | 105 | 21 | int:YWHAZ |
| Interaction | OTUD4 interactions | 4.03e-06 | 236 | 105 | 9 | int:OTUD4 | |
| Interaction | SOX7 interactions | 4.40e-06 | 82 | 105 | 6 | int:SOX7 | |
| Interaction | SALL4 interactions | 4.72e-06 | 83 | 105 | 6 | int:SALL4 | |
| Interaction | FER1L6 interactions | 4.74e-06 | 7 | 105 | 3 | int:FER1L6 | |
| Interaction | SMAP2 interactions | 6.62e-06 | 189 | 105 | 8 | int:SMAP2 | |
| Interaction | PICALM interactions | 9.66e-06 | 263 | 105 | 9 | int:PICALM | |
| Interaction | UVRAG interactions | 1.17e-05 | 97 | 105 | 6 | int:UVRAG | |
| Interaction | TDRD3 interactions | 1.53e-05 | 212 | 105 | 8 | int:TDRD3 | |
| Interaction | YWHAQ interactions | SYNRG PHACTR2 ABI1 PPFIBP2 HECTD4 HNRNPF TRAK1 EEF1A1 GJA1 LATS1 WDHD1 TIAM1 IGHM ERRFI1 NAV1 R3HDM1 PHLDB2 MTSS2 | 1.76e-05 | 1118 | 105 | 18 | int:YWHAQ |
| Interaction | FMR1 interactions | RANBP2 APC2 WBP2NL EWSR1 PABPC1 ZFPM2 EEF1A2 PBRM1 UNK R3HDM1 BSN PRRC2B | 2.29e-05 | 536 | 105 | 12 | int:FMR1 |
| Interaction | NXPH2 interactions | 2.53e-05 | 33 | 105 | 4 | int:NXPH2 | |
| Interaction | NANOG interactions | SOX2 RANBP2 CHERP SALL3 MRPS35 MUC16 POGZ PABPC1 KMT2C PBRM1 SALL1 | 4.23e-05 | 481 | 105 | 11 | int:NANOG |
| Interaction | ATN1 interactions | 5.60e-05 | 187 | 105 | 7 | int:ATN1 | |
| Interaction | R3HDM2 interactions | 5.87e-05 | 129 | 105 | 6 | int:R3HDM2 | |
| Interaction | HNF1B interactions | 6.19e-05 | 190 | 105 | 7 | int:HNF1B | |
| Interaction | YWHAE interactions | SOX2 SYNRG ABI1 PPFIBP2 NCAM2 EWSR1 TRAK1 EEF1A1 ITFG1 EEF1A2 LATS1 TIAM1 ERRFI1 NAV1 UNK R3HDM1 WNK2 PHLDB2 | 8.05e-05 | 1256 | 105 | 18 | int:YWHAE |
| Interaction | TNRC6C interactions | 8.53e-05 | 138 | 105 | 6 | int:TNRC6C | |
| Interaction | ADARB2 interactions | 8.86e-05 | 17 | 105 | 3 | int:ADARB2 | |
| Interaction | DAZL interactions | 1.12e-04 | 145 | 105 | 6 | int:DAZL | |
| Interaction | RGPD1 interactions | 1.23e-04 | 49 | 105 | 4 | int:RGPD1 | |
| Interaction | CELF1 interactions | 1.33e-04 | 288 | 105 | 8 | int:CELF1 | |
| Interaction | TOP3B interactions | SYNRG SETD1B ANXA11 HECTD4 AKNA PABPC1 TRAK1 KMT2C HEYL FAT1 C2CD3 SEC24B OSBPL5 NAV1 UNK SMAP2 WNK2 RIC1 PRRC2B | 1.93e-04 | 1470 | 105 | 19 | int:TOP3B |
| Interaction | MIA3 interactions | 2.08e-04 | 231 | 105 | 7 | int:MIA3 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | TBX15 ATRN RBL2 EWSR1 POGZ ZEB2 FAT1 ERRFI1 NAV1 HACL1 PRKG1 ADAMTS14 TNKS2 PRRC2B PHLDB2 | 1.68e-05 | 1009 | 108 | 15 | M157 |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 1.91e-05 | 199 | 108 | 7 | M9330 | |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN | 1.97e-05 | 200 | 108 | 7 | M8032 | |
| Coexpression | HEVNER_CORTEX_NEURAL_STEM_CELLS | 2.99e-05 | 15 | 108 | 3 | MM406 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ATRN RANBP2 ABI1 ZEB2 TRAK1 GJA1 FAT1 C2CD3 WDHD1 TIAM1 SEC24B VPS13A R3HDM1 | 5.18e-05 | 856 | 108 | 13 | M4500 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_DN | 5.21e-05 | 159 | 108 | 6 | M7734 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | SOX2 ATRN SYNRG RBL2 APC2 HECTD4 AKNA NCAM2 ADGRV1 TRAK1 SSC5D FAT1 C2CD3 NR2E1 WNK2 | 5.02e-06 | 732 | 109 | 15 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ATRN SYNRG RBL2 APC2 HECTD4 AKNA NCAM2 ADGRV1 TRAK1 KMT2C SSC5D FAT1 C2CD3 NR2E1 WNK2 | 6.40e-06 | 747 | 109 | 15 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | SYNRG RBL2 APC2 HECTD4 AKNA NCAM2 TRAK1 KMT2C SSC5D FAT1 C2CD3 SALL1 NR2E1 WNK2 | 1.97e-05 | 722 | 109 | 14 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | SOX2 SYNRG RBL2 APC2 HECTD4 AKNA NCAM2 ADGRV1 TRAK1 KMT2C FAT1 C2CD3 NR2E1 WNK2 | 2.70e-05 | 743 | 109 | 14 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SYNRG RBL2 APC2 HECTD4 AKNA NCAM2 TRAK1 SSC5D FAT1 C2CD3 LATS1 NR2E1 WNK2 | 5.20e-05 | 688 | 109 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | SYNRG RBL2 APC2 HECTD4 AKNA NCAM2 TRAK1 KMT2C SSC5D FAT1 C2CD3 NR2E1 WNK2 | 9.46e-05 | 730 | 109 | 13 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | SOX2 SYNRG RBL2 APC2 HECTD4 AKNA NCAM2 TRAK1 KMT2C FAT1 C2CD3 NR2E1 WNK2 | 1.19e-04 | 747 | 109 | 13 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | SYNRG RBL2 APC2 HECTD4 AKNA NCAM2 SSC5D FAT1 C2CD3 PBRM1 NR2E1 WNK2 | 1.43e-04 | 658 | 109 | 12 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | SYNRG RBL2 APC2 HECTD4 AKNA NCAM2 ADGRV1 TRAK1 SSC5D C2CD3 NR2E1 WNK2 | 1.45e-04 | 659 | 109 | 12 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-07 | 159 | 110 | 7 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.40e-07 | 188 | 110 | 7 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | Healthy_donor-B_cell|Healthy_donor / disease group, cell group and cell class (v2) | 2.16e-06 | 152 | 110 | 6 | 5768edfde8010324d8594815e73bbfba2c3045f3 | |
| ToppCell | Sigmoid-Dendritic_cell-cDC2|Dendritic_cell / Region, Cell class and subclass | 4.66e-06 | 45 | 110 | 4 | 5488dced1d338166f3021509ebe8673e03995978 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.87e-06 | 175 | 110 | 6 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 5.72e-06 | 180 | 110 | 6 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.10e-06 | 182 | 110 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.70e-06 | 185 | 110 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.70e-06 | 185 | 110 | 6 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.12e-06 | 187 | 110 | 6 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.28e-06 | 192 | 110 | 6 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.28e-06 | 192 | 110 | 6 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.53e-06 | 193 | 110 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.01e-05 | 199 | 110 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 147 | 110 | 5 | a82a971a934faff6806823ca62a398b429ecd9c8 | |
| ToppCell | Healthy_donor-B_cell|World / disease group, cell group and cell class (v2) | 3.56e-05 | 150 | 110 | 5 | a2dfed562de7f58f902b547acec5a13853c80c4c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.29e-05 | 156 | 110 | 5 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 157 | 110 | 5 | b72c6a1ed17bfc32d9dec193d934ea82e80b6bd5 | |
| ToppCell | Monocytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.56e-05 | 158 | 110 | 5 | c3096b3a914a1a15ebe3664613e94b951f8555fc | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 161 | 110 | 5 | 274838cebdc7af1db32d309dfe42ef7ccd3c190b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-05 | 162 | 110 | 5 | 8ed9149ff53b285591354057055d072b203a47c8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-05 | 162 | 110 | 5 | 7a05b05a33e1309fb5c0a8171db105ae68491815 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 163 | 110 | 5 | 03d9fa615d9d02ef98e20f28a10aaa6894dd4960 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 163 | 110 | 5 | 1c4de36cf8cdaabb981cda5c7ce7e5ae7b4280e3 | |
| ToppCell | droplet-Liver-Hepatocytes-18m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 163 | 110 | 5 | 7e82c1b7849eca895732df2da74ac6430bd9ba7a | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 5.60e-05 | 165 | 110 | 5 | f012a27ece54c0f7b73a2f4f89c6ee8b865f8782 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.60e-05 | 165 | 110 | 5 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.76e-05 | 166 | 110 | 5 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.10e-05 | 168 | 110 | 5 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-05 | 170 | 110 | 5 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.45e-05 | 170 | 110 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.82e-05 | 172 | 110 | 5 | 55fba5ce0ead1114e1a76f67ad68432c6bac90e5 | |
| ToppCell | Leuk-UTI-Myeloid-cDC1|Leuk-UTI / Disease, Lineage and Cell Type | 7.01e-05 | 173 | 110 | 5 | 226bb8d881f32d65c60f5e4c034c6d465f8e7ba5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.20e-05 | 174 | 110 | 5 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.20e-05 | 174 | 110 | 5 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.20e-05 | 174 | 110 | 5 | 7c8704766dd4c80250754b5ee9907b342b9c2623 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.20e-05 | 174 | 110 | 5 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.20e-05 | 174 | 110 | 5 | 26ca6ebaa0081108d44c01f8ca56a63724f1c99d | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.20e-05 | 174 | 110 | 5 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.20e-05 | 174 | 110 | 5 | 9aa2168d3bcef7cdc5a47442618cb8e9eb24c95b | |
| ToppCell | PND07-Immune|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.60e-05 | 176 | 110 | 5 | 2f87f49b64c6f89823d540172a8e923ebaa6d6cd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.81e-05 | 177 | 110 | 5 | d34b086a5931d7f1737a504952d51c47693e91a8 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.23e-05 | 179 | 110 | 5 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.23e-05 | 179 | 110 | 5 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.23e-05 | 179 | 110 | 5 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | Control-Myeloid-DC1|Control / Condition, Lineage and Cell class | 8.67e-05 | 181 | 110 | 5 | 5a2a1f017ad23baed9972c68b4a46f4c618ef21a | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-05 | 182 | 110 | 5 | 22d6f4790950508e8aa27e02a8133af5f53f13c8 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.90e-05 | 182 | 110 | 5 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.13e-05 | 183 | 110 | 5 | 956ff95aef9c5521b6a3ba7ac6df0aad242c1c35 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.13e-05 | 183 | 110 | 5 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 9.13e-05 | 183 | 110 | 5 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.37e-05 | 184 | 110 | 5 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.37e-05 | 184 | 110 | 5 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 9.61e-05 | 185 | 110 | 5 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Mega-Mast|bone_marrow / Manually curated celltypes from each tissue | 9.61e-05 | 185 | 110 | 5 | a62ebaff92f2ed27b27b32c27c89cfbe2cb35116 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.86e-05 | 186 | 110 | 5 | 73cf266aeecd3cc15e8cb6094588a393bca8fbe6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.86e-05 | 186 | 110 | 5 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.86e-05 | 186 | 110 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 187 | 110 | 5 | 8249b2a69c728e4e04fb14b490c320e644d2252f | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 187 | 110 | 5 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.01e-04 | 187 | 110 | 5 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-04 | 188 | 110 | 5 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-04 | 188 | 110 | 5 | ed92cddf47defea2f904d36c7ae05ffa323349a9 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 188 | 110 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 1.06e-04 | 189 | 110 | 5 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 189 | 110 | 5 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 189 | 110 | 5 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.06e-04 | 189 | 110 | 5 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-04 | 190 | 110 | 5 | 78cc6c28b31de041c24175a98f47da256ecc15a2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-04 | 190 | 110 | 5 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-04 | 190 | 110 | 5 | e67d9400467b438592690b23d681e6c2fb8f09fd | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-04 | 190 | 110 | 5 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | E18.5-samps-Epithelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.09e-04 | 190 | 110 | 5 | 90accc078e9a72329a415d5cefe062c4196bb624 | |
| ToppCell | H1299-infected-SARSCoV1|infected / Cell line, Condition and Strain | 1.09e-04 | 190 | 110 | 5 | f7bfeefc0f30f81710a5ddd979f19b0c910c4a42 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.12e-04 | 191 | 110 | 5 | 1cd4d513ac363fdda07030b85a88174d29af3588 | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 1.12e-04 | 191 | 110 | 5 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 110 | 5 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-04 | 191 | 110 | 5 | cc9a6a8fad17d6e1a08a68ab7512ae06b1249051 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.12e-04 | 191 | 110 | 5 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-04 | 191 | 110 | 5 | c16b920ee69ea8536e020ac3475abf1ce972c1e6 | |
| ToppCell | Control-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.14e-04 | 192 | 110 | 5 | f95fb188aa642f3d0618242a770e7c4b70544adb | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.17e-04 | 193 | 110 | 5 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| ToppCell | Control-Endothelial-Lymphatic|Control / Disease state, Lineage and Cell class | 1.17e-04 | 193 | 110 | 5 | 64d19be73e5432d491436a01da5de5c926b615a9 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.17e-04 | 193 | 110 | 5 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.20e-04 | 194 | 110 | 5 | 7c6c0376603e5fcb64814fd6204d153629c2fbf5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 194 | 110 | 5 | bf34737ae2dc218f890fbb9201c308b324415749 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.20e-04 | 194 | 110 | 5 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 194 | 110 | 5 | b35e33439b6d3b5d69147e617224d2c8fd056223 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 194 | 110 | 5 | 4ebed7a6731b88c8359860072cbeba355a7e90ac | |
| ToppCell | cellseq-Immune-Immune_Myeloid-pMON-pMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-04 | 195 | 110 | 5 | 2cb435dae2691e1250e26e59f9b8fb652a0c383e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.23e-04 | 195 | 110 | 5 | 30ed961151b8b1f6ce37f06c9a061519f01c2864 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 1.23e-04 | 195 | 110 | 5 | 8861c82129f3ef241b1e9fa4825e4621550cee96 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-pMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-04 | 195 | 110 | 5 | 217908cb53016a6cb51f1bc3fc752c8df650df71 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 1.23e-04 | 195 | 110 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 195 | 110 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 15-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 1.23e-04 | 195 | 110 | 5 | 9e9283a397f56732a0a5f2e2527f154d4c2dd56a | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.26e-04 | 196 | 110 | 5 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 1.26e-04 | 196 | 110 | 5 | 2bc67c2346dfb7732e2e6bb273f3da1c5ee6cf0a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-04 | 196 | 110 | 5 | 45d1c0a962c4221c17393ee5566961d1deebf442 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.29e-04 | 197 | 110 | 5 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 4.64e-08 | 3 | 107 | 3 | DOID:0080463 (implicated_via_orthology) | |
| Disease | Amyotrophic Lateral Sclerosis | 5.96e-05 | 58 | 107 | 4 | C0002736 | |
| Disease | epilepsy (implicated_via_orthology) | 3.27e-04 | 163 | 107 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Dickkopf-related protein 4 measurement | 3.60e-04 | 8 | 107 | 2 | EFO_0008110 | |
| Disease | Neurodevelopmental Disorders | 3.72e-04 | 93 | 107 | 4 | C1535926 | |
| Disease | Liver Cirrhosis, Experimental | 5.19e-04 | 774 | 107 | 10 | C0023893 | |
| Disease | Breast Carcinoma | 7.80e-04 | 538 | 107 | 8 | C0678222 | |
| Disease | dickkopf‐related protein 1 measurement | 8.40e-04 | 12 | 107 | 2 | EFO_0010620 | |
| Disease | HOMA-B | 1.06e-03 | 55 | 107 | 3 | EFO_0004469 | |
| Disease | response to olanzapine | 1.33e-03 | 15 | 107 | 2 | GO_0097333 | |
| Disease | Tremor, Rubral | 1.51e-03 | 16 | 107 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.51e-03 | 16 | 107 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 1.51e-03 | 16 | 107 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 1.51e-03 | 16 | 107 | 2 | C0240991 | |
| Disease | Abnormal coordination | 1.51e-03 | 16 | 107 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 1.51e-03 | 16 | 107 | 2 | C0427190 | |
| Disease | carcinoma (implicated_via_orthology) | 1.64e-03 | 64 | 107 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | ZNF366 APC2 CFP COLGALT2 PABPC1 ZEB2 SLC2A2 GJA1 HEYL PBRM1 ZNF541 | 1.81e-03 | 1074 | 107 | 11 | C0006142 |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 2.62e-03 | 21 | 107 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | impotence (biomarker_via_orthology) | 2.87e-03 | 22 | 107 | 2 | DOID:1875 (biomarker_via_orthology) | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 2.87e-03 | 22 | 107 | 2 | EFO_0009312 | |
| Disease | body weight loss | 2.87e-03 | 22 | 107 | 2 | EFO_0005245 | |
| Disease | citrate measurement | 3.00e-03 | 79 | 107 | 3 | EFO_0010114 | |
| Disease | Mammary Carcinoma, Human | 3.06e-03 | 525 | 107 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.06e-03 | 525 | 107 | 7 | C1257931 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.11e-03 | 80 | 107 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | Mammary Neoplasms | 3.13e-03 | 527 | 107 | 7 | C1458155 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.41e-03 | 24 | 107 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.41e-03 | 24 | 107 | 2 | C3805278 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EAPFQSEMYPVPPIT | 81 | A0A1B0GUX0 | |
| SYPQVPGSYPMQPVT | 171 | Q01844 | |
| HKPPSAQQPGPMYTG | 76 | A8MTB9 | |
| QPYASPRPTVSSPKM | 361 | Q8IYX3 | |
| PPSMPPIGLDNVATY | 31 | P50995 | |
| LVPPMEEDYPQFGSP | 476 | P08697 | |
| MEKPPYFPPNLARAT | 2021 | Q8WXG9 | |
| LEPVKPPTVPNDYMT | 201 | Q8IZP0 | |
| KPPMSLEPQNGTYAG | 226 | Q6AI12 | |
| ASMPPTKDNLVPSYP | 496 | Q5T6C5 | |
| PQPPELPGINYSMDE | 466 | Q8WXS8 | |
| KQSPVPKPGPMAYAD | 61 | O95156 | |
| INPDGSPVVYNPPMT | 496 | Q15032 | |
| DPYTPNSLVMPRPDK | 256 | Q9Y620 | |
| TPTKGPVYGMNRLPP | 896 | P49792 | |
| EPVYPKGSPQMKGTP | 106 | Q4ADV7 | |
| PTPMGKGVVPDNHPY | 246 | Q9UJ83 | |
| QPAPPSGYFMAAIPQ | 401 | P11940 | |
| SPGLPPIKPNYDMTL | 451 | P09960 | |
| QANMDAPPLSPYPFV | 1026 | Q08999 | |
| PPNTPVVMVKAIPAY | 381 | Q14517 | |
| PAYSEPPKVTSPMVT | 6611 | Q8WXI7 | |
| MPYTPPQSTPKSAKG | 1356 | Q86U86 | |
| MPRPGKSSYSDQKPP | 1 | Q5VYV0 | |
| EGPAPSQPSYSEQPM | 26 | Q8NDB6 | |
| SSNSRPPSPMDPYAK | 1886 | Q8NEZ4 | |
| KEPSYPMPVQETQAP | 136 | Q7Z434 | |
| TVMPPVAEAPNYQGP | 541 | O95835 | |
| PPFSGPDPMKTYNII | 556 | Q13976 | |
| KMPSQAPTGNFYPQP | 1026 | O75882 | |
| MAPSVPAAEPEYPKG | 1 | P54819 | |
| PVPYLPPKTMTSNLE | 4596 | Q2LD37 | |
| PPVIYSPLMPKGATC | 536 | Q8WW38 | |
| SSAPAMPKKGQPGYP | 3686 | Q9UPA5 | |
| VSQDATYSKPPSPMP | 331 | Q765P7 | |
| VPVKTPTVPDSPGYM | 591 | Q765P7 | |
| ELPTISYSMNPKPTP | 66 | P11168 | |
| MESQGVPPGPYRATK | 1 | Q5TB30 | |
| APMLPSPGKPASYSP | 361 | P09086 | |
| YAAEMEPSPTPTGPL | 156 | Q9NQ87 | |
| NTGKFKSMVPPPPVA | 316 | O75167 | |
| LPKYPPTVSMVEGQG | 411 | P27918 | |
| APSPPAFAKSQPNMY | 296 | P31249 | |
| GPDTAHVPPYPMKIA | 3931 | Q9Y4D8 | |
| PGLASPASYMNPFPV | 36 | Q8ND30 | |
| MGSEPGPAFPTQPQK | 291 | Q5K4E3 | |
| TKVPPPDMTSFPYGT | 611 | Q8NFZ3 | |
| PPFNYVPSPMVVAAT | 2271 | O95996 | |
| MSYKPIAPAPSSTPG | 1 | O75956 | |
| AAEMKSPSPQPPYVR | 86 | Q8WZ55 | |
| PPDSPQMTPGKKSYA | 551 | Q4AC94 | |
| PLSPEKYVTSAPMPE | 371 | P01871 | |
| KYVTSAPMPEPQAPG | 376 | P01871 | |
| PPIQMPGSSEYEAPG | 381 | Q8IWX8 | |
| PAAPQPLQMGPCAYE | 91 | Q8WYQ3 | |
| PGKPMCVESFSQYPP | 406 | Q05639 | |
| QPPQGDVEAMYPALP | 131 | Q06889 | |
| PGKPMCVESFSDYPP | 406 | P68104 | |
| AKRAFLPGMNPPPYS | 141 | Q9GZV9 | |
| APLSPMSPPGYKLVT | 276 | P17302 | |
| MPSPSPKGLPVKQYA | 86 | Q96DP5 | |
| APPAFAYISSVPIMP | 1336 | Q7Z591 | |
| AVFPKPPQDGVYPNM | 236 | Q9Y2E5 | |
| PPQDGVYPNMSEPVT | 241 | Q9Y2E5 | |
| PGKPMCVESFSDYPP | 406 | Q5VTE0 | |
| PYEPDSVVMAEAPPG | 176 | P53990 | |
| MPSANTPFSYPLPKG | 236 | P53990 | |
| PPTMKTSPTVYPVDN | 471 | O43174 | |
| PPMEPSQYVSVVPKY | 321 | Q8IYK4 | |
| APVVPQPSKMAKPFG | 446 | O95487 | |
| IPYGMSIPPEKPVTS | 526 | Q9NSC2 | |
| GIPYGMSLPPEKPVT | 496 | Q9BXA9 | |
| TKVPPPDMTSFPYGT | 611 | Q8N0W4 | |
| MDPSQFNPTYIPGSP | 1 | Q6W0C5 | |
| VVQPNGMPATVYPAP | 121 | A1KXE4 | |
| QPTPKYPHEVNGTPM | 161 | Q9Y466 | |
| YPLSPGKDMEPNGPS | 41 | Q9H0X9 | |
| GYKKPPPATGTATVM | 606 | Q8NEY1 | |
| RPTPATTPEPGIYMF | 26 | P0C841 | |
| DPPLKFMSVQRPGPY | 196 | P52597 | |
| FKPSAVPLPVRMGYP | 76 | P82673 | |
| MYLPGAEVPEPAAPS | 276 | P48431 | |
| PPGPQYTPDMQKQFA | 106 | Q9UMZ2 | |
| KNMYPPPSFPTNKAA | 871 | Q7Z3K3 | |
| PTPPSLPGNSKMEAY | 451 | Q96SF7 | |
| PPGYMPRQEDPHKAT | 846 | Q9UPS6 | |
| MPLGYVPPTAPTDSN | 406 | A1L4H1 | |
| YDGTDKNIPMKPPTP | 96 | Q86SQ0 | |
| MPPTQSFAPDPKYVS | 346 | Q9UJM3 | |
| PPLTSLPGPVYEKCM | 696 | P98171 | |
| LPGPVYEKCMAPPSA | 701 | P98171 | |
| PFMTVSNDLPPKVGP | 186 | Q8IXP5 | |
| YTPKMAVIPSTPPNS | 771 | Q9UPV9 | |
| KEVFPAPPAGFQMAP | 56 | Q8IZ63 | |
| MPDVKESVPPKYPGD | 1 | Q8WWU5 | |
| QMPTPTDVLYVPGPL | 196 | A0A0J9YY54 | |
| YPVKPPKSVTMDSAP | 2666 | Q96RL7 | |
| KMPPAAAEETPPYSN | 271 | Q13009 | |
| EPTVYEFSMPPKPNI | 676 | O15394 | |
| AYPSFPGVTPPNSIM | 296 | Q8WU79 | |
| YDGPMPTPRQKPFQS | 421 | O75717 | |
| PQMPCSVIVYGAPPA | 166 | Q6ICG8 | |
| YSMVTCIFPPVPGPK | 261 | P16471 | |
| TALKPPYSAFPGMQP | 2016 | Q5JSZ5 | |
| GAPKYVPLPGEMAQP | 76 | Q4G0T1 | |
| YPGMPNFAPDEPGKI | 71 | Q15166 | |
| IYKEPPPGMFVVPDT | 111 | Q9H832 | |
| AAMPPSALPSCYKPQ | 796 | Q9H2K2 | |
| VPPQMVPPKGAYNVA | 161 | A7E2V4 | |
| FPQPPRPKYDSQMID | 116 | Q8N895 | |
| VYPAAFPQMAPTDVP | 911 | Q9Y3S1 | |
| PPPPQVVQMYGRKVG | 206 | Q9Y2W2 | |
| MNPFSAKPLYTALPP | 886 | O60315 | |
| KITPFGVNQPGPYIM | 456 | Q8TB96 | |
| MATPYVPVPMPIGNS | 1 | P57768 | |
| SPTQPGPVLYMPSAA | 336 | Q9C0B0 | |
| EGPGSPPPYKMIQTI | 691 | Q13308 | |
| KGLFQCSPYTPPPML | 986 | Q9H0D2 |